Lauren A Beslow Selected Research

Lauren A Beslow Research Topics

7	Stroke (Strokes) 11/2021 - 07/2014
6	Infarction (Infarctions) 02/2020 - 04/2011
5	Ischemic Stroke 09/2021 - 01/2016
4	Brain Edema (Cerebral Edema) 11/2019 - 02/2016
4	Edema (Dropsy) 11/2019 - 02/2016
2	Hemorrhage 01/2018 - 01/2017
1	Craniosynostoses (Craniosynostosis) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 09/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2021
1	Neoplasms (Cancer) 10/2020
1	Thrombosis (Thrombus) 10/2020
1	Epilepsy (Aura) 10/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Hydrocephalus (Hydrocephaly) 01/2017
1	Encephalocele (Encephalocele, Frontal) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Hypertension (High Blood Pressure) 03/2016
1	Renal Insufficiency (Renal Failure) 03/2016
1	Myocarditis (Carditis) 10/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2014
1	Cardiac Arrhythmias (Arrythmia) 10/2014
1	Brain Neoplasms (Brain Tumor) 04/2013

5	Glyburide (Glibenclamide)FDA LinkGeneric 02/2020 - 02/2016
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	ElectrolytesIBA 03/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2014

7	Therapeutics 09/2021 - 04/2011
2	Length of Stay 01/2018 - 03/2016
1	Sutures (Suture) 01/2022
1	Thrombectomy 11/2021
1	Contraindications 09/2021
1	Drug Therapy (Chemotherapy) 10/2020
1	Secondary Prevention 01/2019
1	Craniotomy 01/2017
1	Decompressive Craniectomy 10/2016
1	Transjugular Intrahepatic Portasystemic Shunt 07/2014
1	Thrombolytic Therapy 07/2014
1	Cranial Irradiation 04/2013